Incarceration is associated with multiple and concurrent partnerships, which are determinants of sexually transmitted infections (STI), including HIV. The associations between incarceration and high-risk sex partnerships may exist, in part, because incarceration disrupts stable sex partnerships, some of which are protective against high-risk sex partnerships. When investigating STI/HIV risk among those with incarceration histories, it is important to consider the potential role of drug use as a factor contributing to sexual risk behavior. First, incarceration’s influence on sexual risk taking may be further heightened by drug-related effects on sexual behavior. Second, drug users may have fewer economic and social resources to manage the disruption of incarceration than nonusers of drugs, leaving this group particularly vulnerable to the disruptive effects of incarceration on sexual risk behavior. Using the 2002 National Survey of Family Growth, we conducted multivariable analyses to estimate associations between incarceration in the past 12 months and engagement in multiple partnerships, concurrent partnerships, and unprotected sex in the past 12 months, stratified by status of illicit drug use (defined as use of cocaine, crack, or injection drugs in the past 12 months), among adult men in the US. Illicit drug users were much more likely than nonusers of illicit drugs to have had concurrent partnerships (16% and 6%), multiple partnerships (45% and 18%), and unprotected sex (32% and 19%). Analyses adjusting for age, race, educational attainment, poverty status, marital status, cohabitation status, and age at first sex indicated that incarceration was associated with concurrent partnerships among nonusers of illicit drugs (adjusted prevalence ratio (aPR) 1.55, 95% confidence interval (CI) 1.06–2.22) and illicit drug users (aPR 2.14, 95% CI 1.07–4.29). While incarceration was also associated with multiple partnerships and unprotected sex among nonusers of illicit drugs (multiple partnerships: aPR 1.66, 95% CI 1.43–1.93; unprotected sex: aPR 1.99, 95% CI 1.45–2.72), incarceration was not associated with these behaviors among illicit drug users (multiple partnerships: aPR 1.03, 95% CI 0.79–1.35; unprotected sex: aPR 0.73, 95% CI 0.41–1.31); among illicit drug users, multiple partnerships and unprotected sex were common irrespective of incarceration history. These findings support the need for correctional facility- and community-based STI/HIV prevention efforts including STI/HIV education, testing, and care for current and former prisoners with and without drug use histories. Men with both illicit drug use and incarceration histories may experience particular vulnerability to STI/HIV, as a result of having disproportionate levels of concurrent partnerships and high levels of unprotected sex. We hypothesize that incarceration works in tandem with drug use and other adverse social and economic factors to increase sexual risk behavior. To establish whether incarceration is causally associated with high-risk sex partnerships and acquisition of STI/HIV, a longitudinal study that accurately measures incarceration, STI/HIV, and illicit drug use should be conducted to disentangle the specific effects of each variable of interest on risk behavior and STI/HIV acquisition.
Incarceration Drug use Sexual behavior HIV Sexually transmitted infections US
This study was supported in part by NICHD 1R21HD054293-01A1 (to AAA). Maria Khan was supported as a postdoctoral fellow and Matthew Epperson was supported as a predoctoral fellow in the Behavioral Sciences Training in Drug Abuse Research program, sponsored by the National Development and Research Institutes, Inc. (NDRI) and Public Health Solutions with funding from the National Institute on Drug Abuse (5T32 DA07233).
Maruschak LM. HIV In Prisons, 2005. Washington, DC: Department of Justice, Bureau of Justice Statistics; 2007.Google Scholar
Arriola KR, Braithwaite RL, Kennedy S, et al. A collaborative effort to enhance HIV/STI screening in five county jails. Public Health Rep. 2001;116:520–529.PubMedGoogle Scholar
National Commission on Correctional Health Care. Chapter 3. Prevalence of Communicable Disease, Chronic Disease, and Mental Illness Among the Inmate Population. National Commission on Correctional Health Care; 2002.Google Scholar
Mertz KJ, Schwebke JR, Gaydos CA, Beidinger HA, Tulloch SD, Levine WC. Screening women in jails for chlamydial and gonococcal infection using urine tests: feasibility, acceptability, prevalence, and treatment rates. Sex Transm Dis. 2002b;29:271–276 doi:10.1097/00007435-200205000-00004.PubMedCrossRefGoogle Scholar
Browning S, Miller S, Lisa M. Criminal incarceration dividing the ties that bind: black men and their families. J Afr Am Men. 2001;6:87–102.Google Scholar
Comfort M, Grinstead O, McCartney K, Bourgois P, Knight K. “You can’t do nothing in this damn place”: sex and intimacy among couples with an incarcerated male partner. J Sex Res. 2005;42:3–12.PubMedCrossRefGoogle Scholar
Stephenson BL, Wohl DA, Golin CE, Tien HC, Stewart P, Kaplan AH. Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals. Public Health Rep. 2005;120:84–88.PubMedGoogle Scholar
Grinstead O, Zack B, Faigeles B. Reducing Postrelease Risk Behavior among HIV Seropositive Prison Inmates: The Health Promotion Program. AIDS Educ Prev. 2001;13(2):109–119.PubMedCrossRefGoogle Scholar
Tyndall MW, Patrick D, Spittal P, Li K, O’Shaughnessy MV, Schechter MT. Risky sexual behaviours among injection drugs users with high HIV prevalence: implications for STD control. Sex Transm Infect. 2002;78(Suppl 1):i170–i175.PubMedGoogle Scholar
Khan MR, Miller WC, Schoenbach VJ, et al. Timing and duration of incarceration and high-risk sexual partnerships among African Americans in North Carolina. Ann Epidemiol. 2008;18:403–410.PubMedCrossRefGoogle Scholar
Molitor F, Ruiz JD, Flynn N, Mikanda JN, Sun RK, Anderson R. Methamphetamine use and sexual and injection risk behaviors among out-of-treatment injection drug users. Am J Drug Alcohol Abuse. 1999;25:475–493 doi:10.1081/ADA-100101874.PubMedCrossRefGoogle Scholar
CDC. Drug-associated HIV Transmission continues in the United States. Accessed March 1, 2006. http://www.cdc.gov/hiv/pubs/facts/idu.htm. National Center for HIV, STD and TB Prevention, Divisions of HIV/AIDS Prevention, Centers for Disease Control and Prevention; 2002.
Seal DW, Eldrige GD, Kacanek D, Binson D, Macgowan RJ. A longitudinal, qualitative analysis of the context of substance use and sexual behavior among 18- to 29-year-old men after their release from prison. Soc Sci Med. 2007;65:2394–2406 doi:10.1016/j.socscimed.2007.06.014.PubMedCrossRefGoogle Scholar
Galea S, Vlahov D. Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration. Public Health Rep. 2002;117(Suppl 1):S135–S145.PubMedGoogle Scholar
Catania JA, Gibson DR, Chitwood DD, Coates TJ. Methodological problems in AIDS behavioral research: influences on measurement error and participation bias in studies of sexual behavior. Psychol Bull. 1990;108:339–362 doi:10.1037/0033-2909.108.3.339.PubMedCrossRefGoogle Scholar
Kraut JR, Haddix AC, Carande-Kulis V, Greifinger RB. Cost-effectiveness of routine screening for sexually transmitted disease among inmates in United States prisons and jails. In: The health care needs of soon-to-be-released inmates: a report to the Congress, Volume 2. National Commission on Correctional Health Care; 2002. p. 81–108.Google Scholar